Kenya BioVax Institute Limited, together with the Kenya Vaccine Consortium—comprising AtkinsRéalis, SK Bioscience, and the International Vaccine Institute—officially submitted the Interim Feasibility Study Report for the Smart Vaccine Manufacturing Facility Project to the Principal Secretary for Medical Services, Dr. Ouma Oluga, at Afya House, Nairobi. The meeting marked a key milestone in advancing Kenya’s goal of vaccine self-reliance and regional manufacturing leadership.
